UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms of major depression ...

BUFFALO, N.Y. — University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, ...

A study that investigates low-dose ketamine (LDK) as an adjunct to morphine for treating acute pain has been published in the ...

How can low-dose ketamine, a 'lifesaving' drug for major depression, alleviate symptoms within hours? Date: November 18, 2024 Source: University at Buffalo Summary: Neuroscientists have identified ...

A new study that investigates low-dose ketamine (LDK) as an adjunct to morphine for treating acute pain has been published in ...

University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms ...

University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms ...

Des Plaines, IL — A new study that investigates low-dose ketamine (LDK) as an adjunct to morphine for treating acute pain has been published in the October issue of Academic Emergency Medicine ...

Mental health has long been an area of focus for medical professionals with traditional treatments such as therapy and medication being the go-to solutions for most individuals However in recent years ...

Half will be given ketamine at the dose used in the first clinical trial with psychological therapy. The other half will be given a very low dose of ketamine and a seven-session education package ...